Dr Hugh McMillan is an Associate Professor of Pediatrics at the University of Ottawa, a Pediatric Neurologist and Neuromuscular specialist at the Children’s Hospital of Eastern Ontario (CHEO) and a Clinical Investigator at the CHEO Research Institute. His area of clinical expertise is caring for children and youth with inherited and acquired disorders of peripheral nerve, muscle and neuromuscular junction. He follows children in the Neuro-Oncology clinic as well as a General Child Neurology clinic. His research interests include clinical research, clinical trials (investigator-initiated and sponsor-initiated studies) as well as translational research in cooperation with basic scientists. He has been an author or co-author of more than 55 publications in peer-reviewed journals. He recently co-edited a textbook, “Pediatric Electromyography: Concepts and Clinical Applications”. He is active in the community as a Member of the Muscular Dystrophy Canada Scientific Advisory Board and is the Chair of the Canadian Pediatric Neuromuscular Group.
Elia, N, Nault, T, McMillan, HJ, Graham, GE, Huang, L, Cannon, SC et al.. Corrigendum: Myotonic Myopathy With Secondary Joint and Skeletal Anomalies From the c.2386C>G, p.L796V Mutation in SCN4A. Front Neurol. .11 181 PMID:32265824
Elia, N, Nault, T, McMillan, HJ, Graham, GE, Huang, L, Cannon, SC et al.. Myotonic Myopathy With Secondary Joint and Skeletal Anomalies From the c.2386C>G, p.L769V Mutation in SCN4A. Front Neurol. 2020.11 77 PMID:32117035
Landfeldt, E, Thompson, R, Sejersen, T, McMillan, HJ, Kirschner, J, Lochmüller, H et al.. Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis. Eur. J. Epidemiol. 2020. PMID:32107739
McMillan, HJ, Amid, A, Gonorazky, H, Almobarak, S, Campbell, C. Drisapersen associated with elevated serum factor VIII levels in Duchenne muscular dystrophy. Neurology. 2020.94 (12)538-540 PMID:32075891
Amlie-Lefond, C, Shaw, DWW, Cooper, A, Wainwright, MS, Kirton, A, Felling, RJ et al.. Risk of Intracranial Hemorrhage Following Intravenous tPA (Tissue-Type Plasminogen Activator) for Acute Stroke Is Low in Children. Stroke. 2020.51 (2)542-548 PMID:31842706See more on PubMed